Sanofi to market new hemophilia drug in deal with Alnylam
PARIS (Reuters) - French pharmaceutical group Sanofi said it has obtained the right to develop and sell a new hemophilia drug in a restructuring of its partnership with U.S. Alnylam Pharmaceuticals.
from Reuters: Health News http://reut.rs/2CQXXdL
http://bit.ly/2zwRqiM